T. Rowe Price Investment Management, Inc. Cooper Companies, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$306.88 - $380.0 $6.96 Million - $8.62 Million	22,684 Added 1.25%	1,834,491 $694 Million
Q3 2023 Nov 14, 2023	SELL	$315.92 - $397.36 $58.5 Million - $73.5 Million	-185,037 Reduced 9.27%	1,811,807 $576 Million
Q2 2023 Aug 14, 2023	BUY	$346.15 - $392.09 $4.61 Million - $5.22 Million	13,306 Added 0.67%	1,996,844 $766 Million
Q1 2023 May 15, 2023	SELL	$323.56 - $373.36 $159 Million - $183 Million	-489,876 Reduced 19.81%	1,983,538 $741 Million
Q4 2022 Feb 14, 2023	BUY	$248.67 - $334.17 $775,850 - $1.04 Million	3,120 Added 0.13%	2,473,414 $818 Million
Q3 2022 Nov 14, 2022	BUY	$263.81 - $337.27 $652 Million - $833 Million	2,470,294 New	2,470,294 $652 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.